The Ritedose Corporation recalls Formoterol Fumarate Inhalation Solution
- Recalling company
- The Ritedose Corporation
- Product
- Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
- Reason
- Failed Impurities/Degradation Specification
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Oct 15, 2026
- Reported
- Nov 4, 2026
- Distribution
- Nationwide within the U.S
- Status
- Ongoing
- Quantity
- 3210 Cartons
- Lot / codes
- Lot: 25BL0, Expires: 02/28/2027
- Company location
- Columbia, SC
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0073-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0073-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.